Jak3 contributes to the activation of ALK and Stat3 in ALK+ anaplastic large cell lymphoma

被引:5
作者
Amin, HM
Lin, Q
Lai, R
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Hematopathol, Div Pathol & Lab Med, Houston, TX 77030 USA
[2] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada
[3] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada
关键词
D O I
10.1038/labinvest.3700393
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:417 / 419
页数:3
相关论文
共 17 条
[1]   Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma [J].
Amin, HM ;
Medeiros, LJ ;
Ma, Y ;
Feretzaki, M ;
Das, P ;
Leventaki, V ;
Rassidakis, GZ ;
O'Connor, SL ;
McDonnell, TJ ;
Lai, R .
ONCOGENE, 2003, 22 (35) :5399-5407
[2]   Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog [J].
Boggon, TJ ;
Li, YQ ;
Manley, PW ;
Eck, MJ .
BLOOD, 2005, 106 (03) :996-1002
[3]   Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor [J].
Changelian, PS ;
Flanagan, ME ;
Ball, DJ ;
Kent, CR ;
Magnuson, KS ;
Martin, WH ;
Rizzuti, BJ ;
Sawyer, PS ;
Perry, BD ;
Brissette, WH ;
McCurdy, SP ;
Kudlacz, EM ;
Conklyn, MJ ;
Elliott, EA ;
Koslov, ER ;
Fisher, MB ;
Strelevitz, TJ ;
Yoon, K ;
Whipple, DA ;
Sun, JM ;
Munchhof, MJ ;
Doty, JL ;
Casavant, JM ;
Blumenkopf, TA ;
Hines, M ;
Brown, MF ;
Lillie, BM ;
Subramanyam, C ;
Shang-Poa, C ;
Milici, AJ ;
Beckius, GE ;
Moyer, JD ;
Su, CY ;
Woodworth, TG ;
Gaweco, AS ;
Beals, CR ;
Littman, BH ;
Fisher, DA ;
Smith, JF ;
Zagouras, P ;
Magna, HA ;
Saltarelli, MJ ;
Johnson, KS ;
Nelms, LF ;
Des Etages, SG ;
Hayes, LS ;
Kawabata, TT ;
Finco-Kent, D ;
Baker, DL ;
Larson, M .
SCIENCE, 2003, 302 (5646) :875-878
[4]   Identification of NPM-ALK interacting proteins by tandem mass spectrometry [J].
Crockett, DK ;
Lin, ZD ;
Elenitoba-Johnson, KSJ ;
Lim, MS .
ONCOGENE, 2004, 23 (15) :2617-2629
[5]   The common γ chain (γc) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3 [J].
Habib, T ;
Senadheera, S ;
Weinberg, K ;
Kaushansky, K .
BIOCHEMISTRY, 2002, 41 (27) :8725-8731
[6]   The box1 domain of the erythropoietin receptor specifies Janus kinase 2 activation and functions mitogenically within an interleukin 2 beta-receptor chimera [J].
Jiang, N ;
He, TC ;
Miyajima, A ;
Wojchowski, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16472-16476
[7]   TYROSINE PHOSPHORYLATION AND ACTIVATION OF STAT5, STAT3, AND JANUS KINASES BY INTERLEUKIN-2 AND INTERLEUKIN-15 [J].
JOHNSTON, JA ;
BACON, CM ;
FINBLOOM, DS ;
REES, RC ;
KAPLAN, D ;
SHIBUYA, K ;
ORTALDO, JR ;
GUPTA, S ;
CHEN, YQ ;
GIRI, JD ;
OSHEA, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (19) :8705-8709
[8]   Methylation of SHP1 gene and loss of SHP1 protein expression are frequent in systemic anaplastic large cell lymphoma [J].
Khoury, JD ;
Rassidakis, GZ ;
Medeiros, LJ ;
Amin, HM ;
Lai, R .
BLOOD, 2004, 104 (05) :1580-1581
[9]   Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma [J].
Lai, R ;
Rassidakis, GZ ;
Lin, Q ;
Atwell, C ;
Medeiros, LJ ;
Amin, HM .
HUMAN PATHOLOGY, 2005, 36 (09) :939-944
[10]   SHP-1 expression in peripheral T cells from patients with Sezary syndrome and in the T cell line HUT-78:: implications in JAK3-meidated signaling [J].
León, F ;
Cespón, C ;
Franco, A ;
Lombardía, M ;
Roldán, E ;
Escribano, L ;
Harto, A ;
González-Porqué, P ;
Roy, G .
LEUKEMIA, 2002, 16 (08) :1470-1477